Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 January 2024 | Story Leonie Bolleurs | Photo Supplied
Prof Gert van Zyl
The Dean of the Faculty of Health Sciences, Prof Gert van Zyl, was recently appointed as the Chairperson of the South African Committee of Medical Deans (SACOMD).

The Dean of the Faculty of Health Sciences at the University of the Free State (UFS), Prof Gert van Zyl, was appointed as the Chairperson of the South African Committee of Medical Deans (SACOMD).

Prof Van Zyl, who has been a member of the SA Committee of Medical Deans since 2001, says it is a privilege and a highlight to again serve the health sciences academic community in this very dynamic and special time for medical schools.

He is especially looking forward to working with a brilliant team of deans and leaders in SACOMD, to build on the achievements of the past, and to excel in those areas that they have collectively decided to pursue for the future.

Taking on the role of Chairperson of SACOMD once more, leading with an outstanding team and a shared vision, signifies a special moment in his career, particularly as he approaches the conclusion of a fulfilling journey as dean. During his tenure, Prof Van Zyl was dedicated to actively contributing to stakeholders in the health sciences arena, including the academic community, SACOMD, as well as staff and students at the university.

He is of the opinion that this position brings exceptional value to both the faculty and the university. “It aligns with their collective vision of academic excellence across undergraduate and postgraduate teaching and learning as well as research,” he states.

SACOMD’s strategy for 2024

The Committee’s goal is to facilitate the optimisation and transformation of academic activities in Health Sciences faculties in order to meet the healthcare, research, and social imperatives of the country.

During a strategic session held in 2023, SACOMD determined the following objectives that align with their goal. According to Prof Van Zyl, they will strive to embrace collaboration, establish trust-based relationships among its members, seek proactive and consensus-driven decision-making, share information (drawing knowledge and insights from each other) to collectively advance thought leadership, and leverage their position as an influencer for improved health sciences training and strengthened health systems.

He says there are some exciting trends in a number of areas that will play an important role in advancing medical and health sciences. This includes the role of artificial intelligence, simulation, and robotic surgery in the academic health sciences arena.

As a committee, they will also look at the establishment of work-based assessment as a requirement in the postgraduate training environment of medical specialists in South Africa, the role of higher education academia in a National Health Insurance (NHI) system, as well as improving undergraduate and postgraduate teaching and learning. “All these activities are already guided by a set of detailed actions, responsibility areas, and academic outcomes,” he says.

Furthermore, they will provide support for new medical schools in order to serve the country in producing excellent health professionals. In doing so, they plan to create a more sustainable funding environment, improve the world-class status of training in both undergraduate and postgraduate teaching, and influence important clinical training platforms to support the academic health sciences agenda.

Patients is our first priority

Although operating on a strategic level in serving the health sciences community, Prof Van Zyl also shares his thoughts with students who aspire to pursue a career in this field. “Choose a career for the right reasons. Do not forget that your patients are your first priority in everything you do. Make the most of the opportunity if you are in the privileged position to be selected to study and build a career in health sciences,” he says.

He adds that resilience is an important characteristic when deciding to pursue a career in the medical field. According to him, it is also key to be a team player, have sound mental and spiritual health, and to have compassion in everything you do as a health sciences professional.

“Play this role as a team member, with the oath you have taken and with the Declaration of Geneva’s emphasis on the welfare of patients as your compass. Live this out in your daily professional activities. You are part of a group of professionals known for healing and caring for communities. Play the role required.”

“Mother Theresa said, ‘I alone cannot change the world, but I can cast a stone across the waters to create many ripples.’” “Create your own ripples!” Prof Van Zyl urges aspiring medical professionals.

News Archive

Inaugural lecture: Prof Robert Bragg, Dept. of Microbial, Biochemical and Food Biotechnology
2006-05-17



Attending the inaugural lecture were in front from the left Prof Robert Bragg (lecturer at the Department of Microbial, Biochemical and Food Biotechnology) and Frederick Fourie (Rector and Vice-Chancellor).  At the back from the left were Prof James du Preez (Departmental Chairperson:  Department of Microbial, Biochemical and Food Biotechnology) and Prof Herman van Schalkwyk (Dean: Faculty of Natural and Agricultural Sciences). Photo: Stephen Collett
 

A summary of an inaugural lecture delivered by Prof Robert Bragg at the University of the Free State:

CONTROL OF INFECTIOUS AVIAN DISEASES – LESSONS FOR MAN?

Prof Robert R Bragg
Department of Microbial, Biochemical and Food Biotechnology
University of the Free State

“Many of the lessons learnt in disease control in poultry will have application on human medicine,” said Prof Robert Bragg, lecturer at the University of the Free State’s (UFS) Department of Microbial, Biochemical and Food Biotechnology during his inaugural lecture.

Prof Bragg said the development of vaccines remains the main stay of disease control in humans as well as in avian species.  Disease control can not rely on vaccination alone and other disease-control options must be examined.  

“With the increasing problems of antibiotic resistance, the use of disinfection and bio security are becoming more important,” he said.

“Avian influenza (AI) is an example of a disease which can spread from birds to humans.  Hopefully this virus will not develop human to human transmission,” said Prof Bragg.

According to Prof Bragg, South Africa is not on the migration route of water birds, which are the main transmitters of AI.  “This makes South Africa one of the countries less likely to get the disease,” he said.

If the AI virus does develop human to human transmission, it could make the 1918 flu pandemic pale into insignificance.  During the 1918 flu pandemic, the virus had a mortality rate of only 3%, yet more than 50 million people died.

Although the AI virus has not developed human-to-human transmission, all human cases have been related to direct contact with infected birds. The mortality rate in humans who have contracted this virus is 67%.

“Apart from the obvious fears for the human population, this virus is a very serious poultry pathogen and can cause 100% mortality in poultry populations.  Poultry meat and egg production is the staple protein source in most countries around the world. The virus is currently devastating the poultry industry world-wide,” said Prof Bragg.

Prof Bragg’s research activities on avian diseases started off with the investigation of diseases in poultry.  “The average life cycle of a broiler chicken is 42 days.  After this short time, they are slaughtered.  As a result of the short generation time in poultry, one can observe changes in microbial populations as a result of the use of vaccines, antibiotics and disinfectants,” said Prof Bragg.   

“Much of my research effort has been directed towards the control of infectious coryza in layers, which is caused by the bacterium Avibacterium paragallinarum.  This disease is a type of sinusitis in the layer chickens and can cause a drop in egg product of up to 40%,” said Prof Bragg.

The vaccines used around the world in an attempt to control this disease are all inactivated vaccines. One of the most important points is the selection of the correct strains of the bacterium to use in the vaccine.

Prof Bragg established that in South Africa, there are four different serovars of the bacterium and one of these, the serovar C-3 strain, was believed to be unique to Southern Africa. He also recently discovered this serovar for the first time in Israel, thus indicating that this serovar might have a wider distribution than originally believed.

Vaccines used in this country did not contain this serovar.  Prof Bragg established that the long term use of vaccines not containing the local South African strain resulted in a shift in the population distribution of the pathogen.

Prof Bragg’s research activities also include disease control in parrots and pigeons.   “One of the main research projects in my group is on the disease in parrots caused by the circovirus Beak and Feather Disease virus. This virus causes serious problems in the parrot breeding industry in this country. This virus is also threatening the highly endangered and endemic Cape Parrot,” said Prof Bragg.

Prof Bragg’s research group is currently working on the development of a DNA vaccine which will assist in the control of the disease, not only in the parrot breeding industry, but also to help the highly endangered Cape Parrot in its battle for survival.

“Not all of our research efforts are directed towards infectious coryza or the Beak and Feather Disease virus.  One of my Masters students is currently investigating the cell receptors involved in the binding of Newcastle Disease virus to cancerous cells and normal cells of humans. This work will also eventually lead to a possible treatment of cancer in humans and will assist with the development of a recombinant vaccine for Newcastle disease virus,” said Prof Bragg.

We are also currently investigating an “unknown” virus which causes disease problems in poultry in the Western Cape,” said Prof Bragg.
 
“Although disinfection has been extensively used in the poultry industry, it has only been done at the pre-placement stage. In other words, disinfectants are used before the birds are placed into the house. Once the birds are placed, all use of disinfectants stops,” said Prof Bragg.

“Disinfection and bio security can be seen as the ‘Cinderella’ of disease control in poultry.  This is also true for human medicine. One just has to look at the high numbers of people who die from hospital-acquired infections to realise that disinfection is not a concept which is really clear in human health care,” said Prof Bragg.

Much research has been done in the control of diseases through vaccination and through the use of antibiotics. “These pillars of disease control are, however, starting to crumble and more effort is needed on disinfection and bio security,” said Prof Bragg.

Prof Bragg has been working in close co-operation with a chemical manufacturing company in Stellenbosch to develop a unique disinfectant which his highly effective yet not toxic to the birds.

As a result of this unique product, he has developed the continual disinfection program for use in poultry. In this program the disinfectant is used throughout the production cycle of the birds. It is also used to ensure that there is excellent pre-placement disinfection.

“The program is extensively used for the control of infectious diseases in the parrot-breeding industry in South Africa and the product has been registered in 15 countries around the world with registration in the USA in the final process,” said Prof Bragg.

“Although the problem of plasmid mediated resistance to disinfectants is starting to rear its ugly head, this has allowed for the opening of a new research field which my group will hopefully exploit in the near future,” he said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept